Medical Device News Magazine

R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDEÒ Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

R3 Vascular Inc., a medical device company dedicated to developing [...]

By |2025-01-13T14:45:57+00:00January 13, 2025|3rd Party Medical Device Industry News|Comments Off on R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDEÒ Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery

“Receiving Fast Track designation from the FDA reinforces the potential [...]

By |2025-01-08T15:55:49+00:00January 8, 2025|3rd Party Medical Device Industry News|Comments Off on Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery
Go to Top